We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Lysosomal Activity Changes as Dendritic Cells Mature

By Biotechdaily staff writers
Posted on 24 Mar 2003
Researchers have found that as dendritic cells mature, a physiologic change occurs in their lysosomes, digestive vacuoles within the cytoplasm that facilitate the efficient formation of peptide-MHC class II complexes on the surface of the cells. More...
Their findings were published in the March 7, 2003, issue of Science.

Dendritic cells are the most potent antigen-presenting cells involved in host defense. All immunogenic and tolerogenic responses are initiated upon the recognition of antigen presented by mature dendritic cells, playing an important role in the immune response in cancer and autoimmune diseases.

In response to a variety of stimuli, dendritic cells transform from immature cells specialized for antigen capture into mature cells specialized for T cell stimulation. The physiologic basis of this maturation process was not well understood.

In the current study, investigators from Yale University's Ludwig Cancer Institute (New Haven, CT, USA; www.yale.edu) showed that dendritic cell maturation was accompanied by an acidic shift in lysosomes that favored the production of immune stimulating molecules. In general, lysosomes quickly destroy internalized proteins from bacteria, viruses, or cancer cells and then convert them into individual amino acids that are too small to be recognized by the immune system. However, in mature dendritic cells antigens are sequestered in the lysosomes and then degraded into peptide fragments that are 10-to-15 amino acids in length. These fragments then bind to other molecules, which transport them from lysosomes to the surface of cells.

"Despite rather unfavorable conditions, mature dendritic cells are able to use their lysosomes to warn the immune system,” explained senior author Dr. Ira Mellman, a researcher in the department of cell biology at Yale University School of Medicine. "For 50 years, we have been taught that lysosomes simply degrade all protein they encounter, a situation which would prevent the formation of the large protein fragments required to generate immunity. Dendritic cells have contrived a way around the conventional view of lysosomes by controlling their activities.”

"The fact that lysosomes appear developmentally controlled would explain a key feature of why dendritic cells are so good at what they do,” added Dr. Mellman.

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.